Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
100%
Non-Hodgkin's Lymphoma
96%
Lymphoma
86%
Rituximab
60%
Follicular Lymphoma
54%
Survival
49%
Progression-Free Survival
39%
B-Cell Lymphoma
38%
Hodgkin Disease
34%
Lymphoproliferative Disorders
26%
B-Cell Chronic Lymphocytic Leukemia
25%
Lenalidomide
21%
Mantle-Cell Lymphoma
20%
Cyclophosphamide
20%
Waldenstrom Macroglobulinemia
20%
Therapeutics
19%
Confidence Intervals
18%
B-Lymphocytes
17%
Drug Therapy
16%
Vincristine
16%
Prednisone
16%
Doxorubicin
14%
Neoplasms
14%
T-Cell Lymphoma
14%
Recurrence
13%
Single Nucleotide Polymorphism
12%
Transplants
11%
Hairy Cell Leukemia
11%
Bendamustine Hydrochloride
10%
Incidence
10%
Molecular Epidemiology
10%
Human Herpesvirus 4
10%
Everolimus
9%
Biopsy
9%
Lymphocyte Count
9%
Radiotherapy
9%
Central Nervous System
9%
Odds Ratio
8%
Clinical Trials
8%
Peripheral T-Cell Lymphoma
8%
Genome-Wide Association Study
8%
Cohort Studies
7%
Genetic Variation
7%
Hematologic Neoplasms
7%
Bone Marrow
7%
Maintenance
7%
T-Lymphocytes
6%
Monocytes
6%
Stem Cell Transplantation
6%
Pentostatin
6%